Phase 4 Major Depression Clinical Trials
4 recruitingPhase 4
What is a Phase 4 trial?
Phase 4 trials, also called post-marketing studies, are conducted after a treatment has been approved and is available to the public. They monitor long-term effectiveness and safety in a broader population.
Showing 1–4 of 4 trials
Recruiting
Phase 4
Establishing Multimodal Brain Biomarkers for Treatment Selection in Depression
Major Depressive DisorderChronic Major Depression, Recurrent
University of Texas at Austin50 enrolled1 locationNCT05892744
Recruiting
Phase 4
Establishing Mobile Transcranial Magnetic Stimulation
Treatment Resistant Major Depression
Medical University of South Carolina30 enrolled1 locationNCT06748209
Completed
Phase 4
Escitalopram efficacy and tolerability in treatment resistant depression. an open study.
Major Depression
Lundbeck417 enrolled6 locationsACTRN12613000256774
Not Yet Recruiting
Phase 4
An 8 week randomised, double-blind, placebo controlled trial investigating the role of adjunctive bioactive lipids specifically; docosahexaenoic acid (DHA) versus eicosapentaenoic acid (EPA) in Major Depressive Disorder - with a 6 week open label extension of DHA in patients aged 18-65years.
Major Depression
The Melbourne Clinic90 enrolled1 locationACTRN12610000710022